Xalatan Related Clinical Trials
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). [Completed]
Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma [Recruiting]
Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata [Active, not recruiting]
Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma [Recruiting]
Safety Study of Latanoprost Slow Release Insert [Recruiting]
Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure [Not yet recruiting]
Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [Completed]
Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study [Active, not recruiting]
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [Recruiting]
Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects [Recruiting]
Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature [Recruiting]
Effects of Xal-Ease on Patient Compliance With Xalatan [Recruiting]
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma [Recruiting]
24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma [Completed]
Effects of Anti-Glaucoma Medications on the Ocular Surface [Recruiting]
Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. [Completed]
Efficacy and Safety of 2 Formulations of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension [Recruiting]
Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma [Recruiting]
Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) [Not yet recruiting]
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® [Recruiting]
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy [Not yet recruiting]
Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom [Recruiting]
Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma. [Recruiting]
Topical Application of Latanoprost in Diabetic Retinopathy [Recruiting]
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. [Recruiting]
A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [Completed]
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure [Recruiting]
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers [Completed]
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated [Recruiting]
Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [Withdrawn]
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension [Not yet recruiting]
Treatment of Pediatric Glaucoma [Recruiting]
Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy [Active, not recruiting]
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health [Recruiting]
Comparison of Latanoprost Vs. Timolol [Recruiting]
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension [Recruiting]
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients [Recruiting]
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Recruiting]
Study to Determine if Taking an Over The Counter Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Eye Drops for the Treatment of Glaucoma [Completed]
Long-Term Non-Interventional Latanoprost Study [Recruiting]
Evaluation of Safety of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension [Recruiting]
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects [Recruiting]
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Completed]
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. [Recruiting]
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® [Completed]
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma [Completed]
Corneal Versus Conjunctival Delivery Using a Delivery Device [Withdrawn]
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost [Completed]
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects [Recruiting]
Results of Mass Switch From Latanoprost to Travoprost [Recruiting]
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Completed]
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [Completed]
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma [Completed]
Assessing Ocular Surface Changes After Changing Glaucoma Medications [Recruiting]
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma [Recruiting]
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Cosopt Versus Xalatan [Completed]
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost [Completed]
A Phase 2, Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [Completed]
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma [Recruiting]
Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Recruiting]
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. [Recruiting]
Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients [Completed]
A Study of Different Formulations of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Recruiting]
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops [Recruiting]
Examination of Ocular Surface Effects With Administration of Travatan Z and Xalatan [Recruiting]
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) [Recruiting]
Latanoprost Versus Fotil [Completed]
Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP [Recruiting]
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure [Completed]
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Recruiting]
A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Comparison of Istalolâ„¢ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) [Recruiting]
Pharmacological Intervention in Diabetic Retinopathy [Recruiting]
A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [Active, not recruiting]
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated IOP on a Prostaglandin [Recruiting]
Ocular Surface Effects of Prostaglandin Analogues (PGAs) [Not yet recruiting]
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Completed]
Adjunctive Study of AL-37807 Ophthalmic Suspension [Recruiting]
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Primary Open Angle Glaucoma (POAG) And Ocular Hypertension (OHT) Patients [Completed]
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Circadian Rhythms of Aqueous Humor Dynamics in Humans [Recruiting]
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. [Completed]
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [Completed]
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Completed]
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance [Completed]
Cosopt Versus Xalacom [Completed]
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health [Recruiting]
Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy [Completed]
Assessing Cosopt Switch Patients [Completed]
Lumigan Versus Cosopt [Completed]
|
